| Dr Nkengfack Chateh-nkengtego, MD | |
|
1060 W Perimeter Rd, Jb Andrews, MD 20762-6602 | |
| (240) 612-3783 | |
| Not Available |
| Full Name | Dr Nkengfack Chateh-nkengtego |
|---|---|
| Gender | Female |
| Speciality | Family Medicine |
| Location | 1060 W Perimeter Rd, Jb Andrews, Maryland |
| Accepts Medicare Assignments | Medicare enrolled and may accept medicare through third-party reassignment. May prescribe medicare part D drugs. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1174724082 | NPI | - | NPPES |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 207Q00000X | Family Medicine | D0084118 (Maryland) | Secondary |
| 207Q00000X | Family Medicine | 0101259796 (Virginia) | Primary |
| Entity Name | Kaiser Foundation Health Plan Of The Mid-atlantic States,inc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1043378656 PECOS PAC ID: 3779495858 Enrollment ID: O20080519000558 |
News Archive
Edwards Lifesciences Corporation, a world leader in products and technologies to treat advanced cardiovascular disease, today reported net income for the quarter ended September 30, 2009 of $73.5 million, or $1.25 per diluted share, compared to net income of $32.9 million, or $0.56 per diluted share, for the same period in 2008.
Please be advised that Gallup and Healthways, Inc. today released the Gallup-Healthways Monthly U.S. Well-Being Report for February 2010.
According to a report released Wednesday, the World Health Organization revealed that drug resistant tuberculosis (TB) accounts for about 440,000 cases and 150,000 deaths worldwide each year. The WHO called for better diagnosis and more funding for treatment of the drug-resistant disease that's harder to cure.
Seniors and persons with disabilities have only days left to enroll in or make changes to their Medicare coverage. Open enrollment, known as the Annual Election Period (AEP) began a month earlier this year, on October 15, and will end three weeks earlier than usual, on December 7. The open enrollment period is when recipients may change their Medicare health plan and/or make changes to Medicare Part D prescription drug coverage.
An international team of researchers has found that selpercatinib, a drug that precisely targets cancers driven by mutations or alterations in the gene RET, was effective at shrinking tumours in patients with nonsmall cell lung cancer (NSCLC), with a majority of patients living for more than a year without disease progression.
› Verified 5 days ago
| Entity Name | Lifebridge Community Physicians Inc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1174815807 PECOS PAC ID: 3678751468 Enrollment ID: O20110627000318 |
News Archive
Edwards Lifesciences Corporation, a world leader in products and technologies to treat advanced cardiovascular disease, today reported net income for the quarter ended September 30, 2009 of $73.5 million, or $1.25 per diluted share, compared to net income of $32.9 million, or $0.56 per diluted share, for the same period in 2008.
Please be advised that Gallup and Healthways, Inc. today released the Gallup-Healthways Monthly U.S. Well-Being Report for February 2010.
According to a report released Wednesday, the World Health Organization revealed that drug resistant tuberculosis (TB) accounts for about 440,000 cases and 150,000 deaths worldwide each year. The WHO called for better diagnosis and more funding for treatment of the drug-resistant disease that's harder to cure.
Seniors and persons with disabilities have only days left to enroll in or make changes to their Medicare coverage. Open enrollment, known as the Annual Election Period (AEP) began a month earlier this year, on October 15, and will end three weeks earlier than usual, on December 7. The open enrollment period is when recipients may change their Medicare health plan and/or make changes to Medicare Part D prescription drug coverage.
An international team of researchers has found that selpercatinib, a drug that precisely targets cancers driven by mutations or alterations in the gene RET, was effective at shrinking tumours in patients with nonsmall cell lung cancer (NSCLC), with a majority of patients living for more than a year without disease progression.
› Verified 5 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Dr Nkengfack Chateh-nkengtego, MD 1060 W Perimeter Rd, Jb Andrews, MD 20762-6602 Ph: (240) 612-3783 | Dr Nkengfack Chateh-nkengtego, MD 1060 W Perimeter Rd, Jb Andrews, MD 20762-6602 Ph: (240) 612-3783 |
News Archive
Edwards Lifesciences Corporation, a world leader in products and technologies to treat advanced cardiovascular disease, today reported net income for the quarter ended September 30, 2009 of $73.5 million, or $1.25 per diluted share, compared to net income of $32.9 million, or $0.56 per diluted share, for the same period in 2008.
Please be advised that Gallup and Healthways, Inc. today released the Gallup-Healthways Monthly U.S. Well-Being Report for February 2010.
According to a report released Wednesday, the World Health Organization revealed that drug resistant tuberculosis (TB) accounts for about 440,000 cases and 150,000 deaths worldwide each year. The WHO called for better diagnosis and more funding for treatment of the drug-resistant disease that's harder to cure.
Seniors and persons with disabilities have only days left to enroll in or make changes to their Medicare coverage. Open enrollment, known as the Annual Election Period (AEP) began a month earlier this year, on October 15, and will end three weeks earlier than usual, on December 7. The open enrollment period is when recipients may change their Medicare health plan and/or make changes to Medicare Part D prescription drug coverage.
An international team of researchers has found that selpercatinib, a drug that precisely targets cancers driven by mutations or alterations in the gene RET, was effective at shrinking tumours in patients with nonsmall cell lung cancer (NSCLC), with a majority of patients living for more than a year without disease progression.
› Verified 5 days ago
Brett Rasmussen, MD Family Medicine Medicare: Medicare Enrolled Practice Location: 1060 W Perimeter Rd, Jb Andrews, MD 20762 Phone: 240-612-1143 | |
Miss Rachel Reeder, M.D. Family Medicine Medicare: Medicare Enrolled Practice Location: 1060 W Perimeter Rd, Jb Andrews, MD 20762 Phone: 240-612-3782 Fax: 240-612-3888 | |
Vitu Van, MD Family Medicine Medicare: Accepting Medicare Assignments Practice Location: 1060 W Perimeter Rd, Jb Andrews, MD 20762 Phone: 240-612-2567 | |
Dr. Gregory Chad Kahl, MD Family Medicine Medicare: Medicare Enrolled Practice Location: 1060 W Perimeter Rd, Jb Andrews, MD 20762 Phone: 240-612-4430 | |
Dr. Kevin J Baldovich, M.D. Family Medicine Medicare: Not Enrolled in Medicare Practice Location: 1060 W Perimeter Rd, Jb Andrews, MD 20762 Phone: 240-612-4430 | |
Dr. Jefferson Hopkins Harman Jr., M.D. Family Medicine Medicare: Not Enrolled in Medicare Practice Location: 1050 W Perimeter Rd, Jb Andrews, MD 20762 Phone: 240-612-1267 |